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Identity 
Alias: Bone dysplasia with medullary fibrosarcoma; 
Bone dysplasia with malignant fibrous histiocytoma; 
Hereditary bone dysplasia with malignant change 
 
Note: DMS-MFH is an hereditary bone dysplasia / 
cancer syndrome. 
Inheritance: Autosomal dominant; rare hereditary 
cancer syndrome with only four families identified 
worldwide; etiology unknown. 
Clinics 
Note 
Radiologic evidence of bone dysplasia not evident in 
childhood; X-ray findings become apparent during 
adolescence. 
Phenotype and clinics 
Main features include: 
- Bone dysplasia (100%) 
- Cortical growth abnormalities: diaphyseal medullary 
stenosis with overlying endosteal cortical thickening 
and scalloping, metaphyseal striations, scattered 
sclerotic areas symmetrically affecting the long bones; 
bilateral mandibular radiolucent and sclerotic lesions 
- Bone infarctions 
- Pathologic fractures: subsequent poor healing or non-
union 
- Progressive wasting or bowing of the lower 
extremities 
- bone pain 
- Pre-senile cataracts (25%) 
 
 
Photograph A: Lateral X-ray view of the left tibia and fibula of an 18 year old male with DMS-MFH and MFH. Note the extensive 
diaphyseal cortical thickening, areas of resultant medullary stenosis, endosteal irregularities, overall permeative pattern in the medullary 
cavity, and metaphyseal striations. 
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Photograph B: Tibia and MFH of patient shown in Photograph A. The MFH tumor was associated with the infarcted area in the proximal 
tibia. Hematoxylin and eosin preparation shows removed MFH tumor from infarcted area with typical storiform arrangement of spindle 
cells throughout the view. 
 
- Bone malignant fibrous histiocytoma (MFH) (35%) 
Diagnosis: X-ray skeletal findings are unique; however, 
there may be some radiologic overlap with other 
diaphyseal dysplasias including Camurati-Engelman 
and Kenny-Caffey diseases and radiation osteitis; no 
hematologic or urinary markers of disease have been 
identified; 201Thallium chloride radionucleotide scans 
may offer discrimination between areas of increased 
metabolic bone activity found in DMS-MFH patients 
and malignant change. 
Neoplastic risk 
Thirteen cases of osseous MFH; thirty-five per cent of 
DMS-MFH patients develop MFH; the age distribution 
has been from the second to fifth decades; no sex 
predilection; in its sporadic form, MFH represents 
approximately 6% of all bone cancers and is the most 
frequently occurring adult soft-tissue sarcoma. 
Treatment 
No known treatment for the dysplasia; the tumors are 
highly aggressive - treated with surgical ablation and 
the same chemotherapeutic regimens as osteosarcoma; 
it is believed that preoperative chemotherapy improves 
surgical outcome. 
Evolution 
The disease becomes radiologically apparent only in 
adolescence: however, retrospectively, clinical signs 
and symptoms may be evident in childhood; these 
include unexplained bone pain and pathologic 
fractures; in some, crippling pain and weakness of the 
lower extremities ensues following the sixth decade; 
malignancy occurs most frequently between the second 
to fifth decades and is particularly aggressive; only two 
long-term survivors, greater than five years, are known; 




Collagen fibrils from the endosteal surface of bones 
appear frayed and unraveled (npublished results); 
chemical crosslink analysis of bone biopsy samples 
reveal altered hydroxylysylpyridinolin (HP) / 
lysylpyridinoline (LP) ratios (unpublished results). 
Genes involved and proteins 
Note 
The gene has been mapped by linkage analysis to a 3 
cM region on chromosome 9p21-22; all families used 
in the study generated positive LOD scores in this 
region and all affecteds had similar phenotypic findings 
consistent with the syndrome being genetically 
homogeneous; a number of genes in the region, 
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including p15 and p16, have been excluded as the 
DMS-MFH gene by DNA sequencing analysis; under 
the hypothesis that hereditary and sporadic MFH 
tumors are genetically identical, the DMS-MFH tumor-
suppressor gene region has been further narrowed to 
1.5 cM using loss of heterozygosity analysis; the 
continued search for the common minimally deleted 
region in MFH tumors should provide the most 
powerful method for gene identification. 
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